Overview
Doo Chung practices in Seoul, Republic of Korea. Chung is rated as an Advanced expert by MediFind in the treatment of Lung Adenocarcinoma. Their top areas of expertise are Lung Cancer, Lung Adenocarcinoma, Non-Small Cell Lung Cancer (NSCLC), and EGFR Positive Lung Cancer.
Their clinical research consists of co-authoring 158 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 19 articles in the study of Lung Adenocarcinoma.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Lung CancerChung isDistinguished. Learn about Lung Cancer.
- Advanced
- EGFR Positive Lung Cancer
- Lung AdenocarcinomaChung isAdvanced. Learn about Lung Adenocarcinoma.
- Non-Small Cell Lung Cancer (NSCLC)
- Experienced
- Acute Interstitial PneumoniaChung isExperienced. Learn about Acute Interstitial Pneumonia.
- ArthritisChung isExperienced. Learn about Arthritis.
- AsthmaChung isExperienced. Learn about Asthma.
- Cerebral HypoxiaChung isExperienced. Learn about Cerebral Hypoxia.
- Idiopathic Pulmonary FibrosisChung isExperienced. Learn about Idiopathic Pulmonary Fibrosis.
- Infant Respiratory Distress Syndrome